Activation of PI3K/mTOR pathway occurs in most adult low-grade gliomas and predicts patient survival
| 详细信息 | 推荐本文 | |
- 作者：Sean M. McBride ; Daniel A. Perez ; Mei-Yin Polley ; Scott R. Vandenberg ; Justin S. Smith ; Shichun Zheng ; Kathleen R. Lamborn ; John K. Wiencke ; Susan M. Chang and Michael D. Prados ; et al.
- 关键词：Low grade glioma ; mTOR ; Rapamycin ; PTEN ; PRAS40
- 刊名：Journal of Neuro-Oncology
- 出版时间：March, 2010
- 出版年：2010
- 期刊代码：45_0167594X
- 类别：ch
- 卷：97
- 期：1
- 页码：33-40
- 数据来源：sp
摘要
Recent evidence suggests the Akt-mTOR pathway may play a role in development of low-grade gliomas (LGG). We sought to evaluate whether activation of this pathway correlates with survival in LGG by examining expression patterns of proteins within this pathway. Forty-five LGG tumor specimens from newly diagnosed patients were analyzed for methylation of the putative 5′-promoter region of PTEN using methylation-specific PCR as well as phosphorylation of S6 and PRAS40 and expression of PTEN protein using immunohistochemistry. Relationships between molecular markers and overall survival (OS) were assessed using Kaplan-Meier methods and exact log-rank test. Correlation between molecular markers was determined using the Mann-Whitney U and Spearman Rank Correlation tests. Eight of the 26 patients with methylated PTEN died, as compared to 1 of 19 without methylation. There was a trend towards statistical significance, with PTEN methylated patients having decreased survival (P = 0.128). Eight of 29 patients that expressed phospho-S6 died, whereas all 9 patients lacking p-S6 expression were alive at last follow-up. There was an inverse relationship between expression of phospho-S6 and survival (P = 0.029). There was a trend towards decreased survival in patients expressing phospho-PRAS40 (P = 0.077). Analyses of relationships between molecular markers demonstrated a statistically significant positive correlation between expression of p-S6(235) and p-PRAS40 (P = 0.04); expression of p-S6(240) correlated positively with PTEN methylation (P = 0.04) and negatively with PTEN expression (P = 0.03). Survival of LGG patients correlates with phosphorylation of S6 protein. This relationship supports the use of selective mTOR inhibitors in the treatment of low grade glioma.